ACRIPTEGA (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg) x 90 TABLETS.

ACRIPTEGA (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg) x 90 TABLETS.
Generic name: Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate.
Brand name: Mylan.
Class: Antiretroviral.
Pack size: 90 tablets.
Form: Tablets.
Strength: 50/300/300 mg.
Amount: ₦‎7,500

Description: This combination tablet is a potent antiretroviral medication used in the treatment of Human Immunodeficiency Virus (HIV) infection. The formulation combines three active ingredients: Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate, each of which plays a crucial role in controlling HIV. By inhibiting viral replication, this medication helps manage HIV infection, reducing viral load, and increasing CD4 cell counts, thereby improving the immune system's function and slowing the progression of the disease.

Key features:
• Combines Dolutegravir (50 mg), Lamivudine (300 mg), and Tenofovir Disoproxil Fumarate (300 mg) for a comprehensive approach to HIV treatment.
• Convenient once-daily tablet enhances patient compliance and ease of use.
• Helps in reducing viral load to undetectable levels, improving immune function.
• Ensures all three drugs are administered together, reducing the pill burden.

Side effects:
• Common side effects include headache, fatigue, nausea, diarrhoea, and insomnia.

Caution:
• To be used under the guidance of a healthcare provider experienced in HIV management.
• Caution when taken with other medications, especially those that affect kidney function or those that are also metabolized by the liver.
• The medication can be used during pregnancy but under strict medical supervision. Not recommended during breastfeeding due to the potential risk of passing the medication to the baby.
• It is crucial to adhere to the prescribed regimen to prevent the development of drug resistance.